Verbatim response from Perplexity
Usually, no—compounded GLP-1s are not the best default option if Wegovy was denied. The FDA says compounded drugs should generally be used only when a patient’s medical need cannot be met by an FDA-approved drug, and compounded GLP-1s are not FDA approved or reviewed for safety, effectiveness, or quality.[1][12]
What that means in practice:
- First choice: appeal the Wegovy denial and check whether your plan covers another FDA-approved obesity medication or a different GLP-1 option that is clinically appropriate.[13][9]
- Second choice: if you truly cannot access an FDA-approved option because of a shortage or a specific medical need, a compounded product may be considered, but only with careful pharmacy and prescriber oversight.[1][9]
- Not ideal as routine care: the ADA recommends against non-FDA-approved compounded GLP-1s because of safety, quality, effectiveness, and content-uncertainty concerns.[13]
Why compounded GLP-1s are riskier:
- They are not FDA-approved, so the FDA does not review them for safety or quality before they are marketed.[1][2]
- Some compounded products may use salt forms or added ingredients that are not proven safe/effective for weight loss.[6]
- Medical organizations have warned that compounded products can vary in dose, purity, and consistency.[11][13]
When compounded GLP-1s might make sense:
- You cannot get an FDA-approved product because of a true shortage or another documented access barrier.[1][9]
- Your prescriber has a specific medical reason the branded drug cannot meet your needs, such as a different dosage form or preservative-free formulation.[1][9]
What I’d recommend you do next:
- Ask your prescriber to appeal the Wegovy denial with documentation of medical necessity.
- Ask your insurer whether they cover Zepbound, Saxenda, Victoza, Ozempic, Mounjaro, or Rybelsus if one of those is appropriate for your situation.[6][13]
- If you still consider compounded treatment, use only a state-licensed pharmacy and make sure the prescription is tied to a clear clinical reason—not just lower cost.[1]
If you want, I can help you compare Wegovy appeal vs. compounded semaglutide vs. other FDA-approved alternatives based on your budget, diagnosis, and what your plan denied.